CareFusion Buys Its U.K. Distributor

In short

CareFusion today announced the acquisition of U.K. Medical Limited, a leading distributor of medical products (including CareFusion’s own Interventional Technologies range) to the National Health Service (NHS) and private health care sector in the United Kingdom.

Background

The acquisition, terms of which were not disclosed, is Carefusion’s fifth and according to a press release issued today forms part of the company’s strategy to expand globally by investing to build scale, infrastructure and local capabilities in key markets.

U.K. Medical served as the sole U.K. distributor of CareFusion’s Interventional Technologies portfolio, including soft-tissue and bone marrow biopsy needles, the AVAmax® Advanced Vertebral Augmentation System and the PleurX® Peritoneal Catheter Drainage System. It specialises in medical technologies including products used in interventional radiology and for surgical and vascular access in acute-care hospitals. Over the past three years, CareFusion says U.K. Medical has contributed to a nearly 50 percent growth of its Interventional Technologies portfolio in the United Kingdom.

U.K. Medical markets medical products for approximately 10 additional suppliers.

Company comments

for Carefusion

“The acquisition further strengthens CareFusion’s presence in the United Kingdom, where we have built leadership positions in infusion therapy and infection prevention,” said Gordon LaFortune, executive vice president of International Commercial Operations for CareFusion. “We believe this acquisition will help us expand our long-standing partnership with U.K. Medical and better leverage the company’s clinical expertise to continue to grow our Procedural Solutions business in the United Kingdom and beyond.”

for U.K. Medical

“For more than 30 years, we have served the NHS and private medical sector with high-quality, high-technology medical products to help improve patient care pathways,” said Jim Mackenzie, chairman of U.K. Medical. “We look forward to continuing our track record of growth and innovation with CareFusion.”

Source: Carefusion, PR Newswire